Results 181 to 190 of about 53,816 (275)

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents [PDF]

open access: yes, 2017
Abraham, Christopher   +14 more
core   +2 more sources

Epilepsy: Molecular Pathogenesis and Emerging Therapies

open access: yesMedComm, Volume 7, Issue 4, April 2026.
Progress has been made in the molecular pathogenesis of epilepsy, revealing multiple therapeutic targets. Recent advances in pharmacology, materials science, and surgical technique, coupled with progress in targeted therapy and disruptive epilepsy network technology, have led to the emergence of innovative strategies for epilepsy treatment.
Wanbin Huang   +5 more
wiley   +1 more source

Automated evaluation of organ sparing in prostate stereotactic body radiation therapy using dose-gradient metrics. [PDF]

open access: yesPhys Imaging Radiat Oncol
De Kerf G   +5 more
europepmc   +1 more source

Intraocular Metastasis: Differential Diagnosis and Management

open access: yesClinical &Experimental Ophthalmology, Volume 54, Issue 3, Page 382-397, April 2026.
ABSTRACT Intraocular metastases represent the most common type of malignant intraocular tumour in adults. These commonly affect the choroid but can also involve the iris, ciliary body, retina, vitreous, optic disc or lens. Breast and lung cancer are the most common origins of intraocular metastases.
Genovefa Μachairoudia   +3 more
wiley   +1 more source

Organ preservation with total neoadjuvant therapy in early‐stage rectal cancer: A statewide analysis

open access: yesColorectal Disease, Volume 28, Issue 4, April 2026.
Abstract Background The standard treatment for early‐stage (cT2‐3N0) rectal adenocarcinoma is upfront Total Mesorectal Excision (TME), but the desire for organ preservation has seen the increasing use of neoadjuvant therapy in these patients. Owing to its likely higher complete response rate, Total Neoadjuvant Therapy (TNT) is an attractive but ...
Zachary Bunjo   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy